CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection - Therapeutic implications;Les lymphocytes CD4 cibles et acteurs dans la pathogenèse de l'infection à VIH - Conséquences thérapeutiques

Bulletin de l'Academie Nationale de Medecine

Volumn 192, Issue 7, 2008, Pages 1453-1468

  Theze, Jacques ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

CD4 positive T lymphocytes; HIV; Therapeutics

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CCR7 PROTEIN, HUMAN; CHEMOKINE RECEPTOR CCR7; IL7 PROTEIN, HUMAN; INTERLEUKIN 2; INTERLEUKIN 7;

ACUTE DISEASE; AUTOCRINE EFFECT; BLOOD; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; DISEASE COURSE; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOPOIESIS; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY; REVIEW; VIREMIA; VIROLOGY;

ACUTE DISEASE; ANTI-HIV AGENTS; AUTOCRINE COMMUNICATION; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CHEMOTAXIS, LEUKOCYTE; DISEASE PROGRESSION; HIV; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HUMANS; IMMUNOLOGIC MEMORY; INTERLEUKIN-2; INTERLEUKIN-7; LYMPHOCYTE ACTIVATION; LYMPHOPOIESIS; RECEPTORS, CCR7; VIREMIA;

EID: 67649229641     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)32693-7     Document Type: Article

References (20)

1. LE POINT SUR L'ÉPIDÉMIE DE SIDA -RAPPORT OMS-ONUSIDA (2007) WWW.UNAIDS.ORG
2. [2] SIMON V., HO D., ABDOOL KARIM Q. -HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet. 2006, 368, 489-504. (Pubitemid 44142771)
3. THEZE J., DEBRE P. -L'infection à VIH : aspects physiopathologiques et génétiques. In Annales de l'Institut Pasteur I Actualités, (J. Thèze and P. Debré, Eds, Elsevier Publisher), 2000.
4. THEZE J. -The Cytokine Network and Immune Functions. Oxford University Press (Publisher), 1999.
5. [5] APPAY V., SAUCE D. -Immune activation and inflammation in HIV-I infection: causes and consequences. J. Pathol. 2008, 274, 231-241. (Pubitemid 351160160)
6. [6] ALATRAKNI N., DUVIVIER C., COSTAGLIOLA D., SAMRI A., MARCELIN A.G., KAMKAMIDZE G. et al. -Persistant low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication. AIDS, 2005, 19, 25-33. (Pubitemid 40111015)
7. [7] DAVID D., BANI L., MOREAU J.L., DEMAISON C., SUN K., SALVUCCI O., NAKARAI T. et al. - Further analysis of interleukin-2 receptor subunit expression on the different human peripheral blood mononuclear cells subsets. Blood, 1998, 91, 165-172. (Pubitemid 28018741)
8. [8] DAVID D., CHEVRIER D., TREILHOU M.-P., JOUSSEMET M., DUPONT B., THEZE J. et al. -IL-18 under-expression reduces IL-2 levels during HIV infection: a critical step towards the faulty cell-mediated immunity. AIDS, 2000, 14, 2212-2214. (Pubitemid 30792501)
9. [9] DAVID D., BANI L., MOREAU J.L., TREILHOU M.D. , NAKARAI T., JOUSSEMET M. et al. - Regulatory dysfunction of the Interleukin-2 receptor during HIV-infection and the impact of triple combination therapy. PNAS, 1998, 95, 11348-11353. (Pubitemid 28450131)
10. [10] KRYWORUCHKO M., PASQUIER V., KELLER H., DAVID D., GOUJARD C., GILQUIN J. et al. - Defective IL-2-dependent STAT 5 signaling in CD8 T lymphocytes from HIV-positive patients: restoration by antiretroviral therapy. AIDS, 2004, 18, 421-426. (Pubitemid 38365868)
11. [11] KRYWORUCHKO M., PASQUIER V., THEZE J. -Human Immunodeficiency Virus -1 envelope glycoproteins and anti-CD4 antibodies inhibit Interleukin-2 induced Jack/STAT signaling in human CD4 T lymphocytes. Clin. Exp. Immunol., 2003, 131, 422-427. (Pubitemid 36324132)
12. [12] NAPOLITANO LA., GRANT RM., DEEKS SG., SCHMIDT D., DE ROSA SC., HERZENBERG LA. et al. - Increased production of IL-7 accompanies HIV-1 mediated T-cell depletion: implications for T-cell homeostasis. Nat. Med, 2001, 73-79. (Pubitemid 32095644)
13. COLLE J.H., MOREAU J.L., FONTANET A., LAMBOTTE O., JOUSSEMET M., DELFRAISSY J.F. et al. - CD 127 expression and regulation are altered in the memory CD8 T cells of HIV-infected patients -reversal by highly active anti-retroviral therapy (HAART). Clin. Exp. Immunol., 2006, 143, 398-403.
14. BEQ S., RANNOU M.T., FONTANET A., DELFRAISSY J.F., THEZE J., COLLE J.H. -HIV infection: Pre-HAART IL-7 plasma levels correlate with long term CD4 count increase after treatment. AIDS, 2004, 18, 563-565.
15. [15] LAMINE A., CAUMONT-SARCOS A., CHIX ML., SAEZ-CIRION A., ROUZIOUX C., DELFRAISSY JF. et al. -Replication-competent HIV strains infect HIV controllers despite undetectable viremia (ANRS EP36 study). AIDS, 2007, 21, 1043-1045. (Pubitemid 46684337)
16. POTTER S., LACABARATZ C., LAMBOTTE O., PEREZ-PATRIGEON S., VINGERT B., SINET M. et al. - Preserved central memory and activated effector memory CD4 + T cell subsets in HIV controllers: an ANRS EP36 study. J. Virol, 2007, 57, 13904-13915.
17. [17] SAEZ-CIRION A., LACABARATZ C., LAMBOTTE O., VERSMISSE P., URRITIA A., BOUFASSA F. et al. - HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. PNAS, 2007, 104, 6776-6781. (Pubitemid 47175577)
18. [18] DAVID D., NAÏT-IGHIL L., DUPONT B., MARAL J., GACHOT B., THEZE J. -Rapid effect of IL-2 therapy in HIV-infected patients whose CD4 counts increase only slightly in response to combined anti-retroviral treatment. J. Infec. Dis., 2001, 183, 730-735. (Pubitemid 32171747)
19. [19] KATLAMA C., CARCELAIN G., DUVIVIER C., CHOUQUET C, TUBIANA R., DE SA M. ZAGURY L. et al. -Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study -ANRS 082. AIDS, 2002, 16, 2027-2034. (Pubitemid 35205266)
20. [20] DURIER C., CAPITANT C., LASCAUX AS., GOUJARD C., OKSENHENDLER E., POIZOT-MARTIN L. et al. -Long term effects of intermittent interleukin-2 therapy in chronic HIV-infected patients (ANRS 048-079 Trials). AIDS, 2007, 27, 1887-1897. (Pubitemid 47329765)